Medical Education in Prostate Cancer
Medical Education in Prostate Cancer
At Johnson & Johnson, our ambition is to help eliminate prostate cancer. Through collaboration with patients, caregivers, and healthcare professionals – including leading specialists – we are driven to make our ambition a reality. With over 30 years of innovation in oncology, we are working to get in front of prostate cancer by harnessing the power of precision medicine and developing the next wave of therapeutics.
Our prostate cancer platform provides up-to-date resources, tools and expert insights to support informed decision-making.
Featured Prostate Cancer Events
Join our upcoming symposia and webinars hosted by our leading specialists. Register for events and access to post event recordings and materials available exclusively for J&J Medical Cloud users.
17–21 October 2025
ESMO 2025
Berlin, Germany
Join us at our GU session: ‘The power of precision medicine: Transforming patient outcomes in GU oncology’
13-16 November 2025
EMUC 2025
Prague, Czech Republic
Join us in person or virtually at EMUC 2025 - 'Driving optimal patient outcomes with personalised strategies in mHSPC'
If you miss the live event, our satellite will also be available to access on demand.
13-16 March 2026
EAU 2026
London, United Kingdom
We are excited to be hosting our 2nd workshop on diversity in GU and a prostate cancer symposium at EAU 2026.
Register or sign in for J&J Medical Cloud to unlock access to upcoming events, stay updated on the latest educational opportunities, and connect with a network of healthcare professionals.
Recently Added
Explore the latest educational content on our website, featuring expert-led sessions, insights from KOLs, and practical tools designed to support your continuous learning and enhance your clinical practice.
ESMO 2025
The power of precision medicine: Transforming patient outcomes in GU oncology
An expert panel – including Dr. Elena Castro, Prof. Dr. Axel Heidenreich, and Dr. Alejo Rodríguez-Vida – will examine key clinical considerations in GU cancer care.
UROonco 2025
Our prostate cancer session – ‘(Bio) Markers and milestones at the crossroads of mHSPC’ – explored the latest developments and challenges in the field.
Key Highlights
Johnson & Johnson’s Young Experts in Science (YES) Meeting
Our annual meeting - for those earlier in their career specialisation in prostate cancer, focuses on networking, interactive scientific discussions, and enhancing specific skills to improve patient care across the EMEA region by best practice sharing.
Introducing J&J withMe
A patient-centric platform designed to support patients throughout their healthcare journey. It provides personalised, high-quality content and services to enhance patient engagement.
By empowering informed, proactive patients, J&J withMe helps improve treatment outcomes.
Learn how this platform can strengthen your patient relationships — explore J&J withMe today!
Prostate Cancer Learning Centre
Discover educational content designed to enhance your daily practice. Our Learning Centre is dedicated to addressing the evolving needs of healthcare professionals and fostering the diverse skill set essential for delivering high-quality care.
Events Centre
Stay informed with our Event Centre – your hub for medical education events, expert faculty interviews, and clinical insights. Browse on-demand content from past events and hear from leaders shaping patient care.
Expert Insights: Answers from Key Opinion Leaders
Gain valuable insights from leading experts in the field as they share their knowledge on key topics and provide informed answers to common questions. Stay informed and enhance your understanding with expert perspectives!
What is the value of earlier testing in metastatic prostate cancer?
What is the value of earlier testing in metastatic prostate cancer?
The importance of early testing in metastatic prostate cancer (mPC) – filmed at ASCO 2025
Prof. Eleni Efstathiou, Prof. Gert Attard, Dr. Elena Castro, and Dr. Brigida Maiorano examine the latest trials and discuss the need for earlier testing in mPC to aid treatment decisions.
What new mechanisms of action are coming to the prostate cancer space?
What new mechanisms of action are coming to the prostate cancer space?
.jpeg?width=1179&height=781&format=webp&quality=50)
New mechanisms of action in prostate cancer treatment – filmed at ASCO 2025
Dr. Joaquin Mateo, Dr. Andrew Parsonson, and Dr. Capucine Baldini discuss promising mechanisms of action in the prostate cancer space, including antibody-drug conjugates, bispecific antibodies, and combination therapies.
Note: To access more expert insights, you can register or sign in to J&J Medical Cloud. Stay informed about the latest educational resources and updates from Johnson & Johnson Innovative Medicine by signing up for our communications.
Our Commitment
Therapeutic Areas
Our scientists and researchers are pioneering the path from lab to life and championing patients each step of the way.
Expert-Driven Education
Our educational programs are developed and reviewed in partnership with a global network of healthcare leaders.
Our Partnerships
We are committed to partnering with medical societies to enhance healthcare outcomes and foster professional education.
Connecting Scientific Expertise
Supporting healthcare professionals to engage in ongoing discussions about the latest scientific advancements.
Our Responisbility to Medical Education
Stay in Touch
We value your connection. Sign up to stay informed about the latest educational resources, and updates. By subscribing, you'll receive timely notifications and exclusive content tailored to your interests.
Contact us
If you would like to report an Adverse Event (medication side effect) and/or Product Quality Complaint (problem with one of our products), please select one of the links on our contact us page. To submit a medical information request, please visit the designated page.
CP-540401 - October 2025
